[Screening for asymptomatic Chlamydia trachomatis infection: cost-effectiveness favorable at a minimum prevalence rate of 3% or more]

Ned Tijdschr Geneeskd. 2001 Mar 10;145(10):499-501.
[Article in Dutch]
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adult
  • Chlamydia Infections / economics*
  • Chlamydia Infections / epidemiology
  • Chlamydia Infections / prevention & control*
  • Chlamydia Infections / urine
  • Chlamydia trachomatis / isolation & purification*
  • Cost-Benefit Analysis
  • Female
  • Humans
  • Mass Screening / economics
  • Netherlands / epidemiology
  • Pregnancy
  • Pregnancy Complications, Infectious / economics*
  • Pregnancy Complications, Infectious / epidemiology
  • Pregnancy Complications, Infectious / microbiology
  • Pregnancy Complications, Infectious / prevention & control*
  • Pregnancy Complications, Infectious / urine
  • Prevalence